Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Crucell subsidiary ends animal testing

This article was originally published in Scrip

Executive Summary

Crucell's Swiss subsidiary Berna Biotech is to close its animal testing facility in Bern, Switzerland, after successfully completing its 3R programme – to Reduce, Refine and Replace all animal testing. Crucell acquired Berna Biotech in 2006 and all of the subsidiary's tests have now been replaced by in vitro assays and any products that were absolutely dependent on animal testing are to be discontinued. The closure of the biotech facility will negatively affect only a few of Crucell's employees as most will be relocated to other departments in its Bern offices, the company said.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts